 id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">WHO. Global tuberculosis report 2017. Geneva: World Health Organization; 2017.</mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">WHO. Global tuberculosis report 2012. Geneva: World Health Organization; 2012.</mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>CJL</given-names></name><name><surname>Vos</surname><given-names>T</given-names></name><name><surname>Lozano</surname><given-names>R</given-names></name><name><surname>Naghavi</surname><given-names>M</given-names></name><name><surname>Flaxman</surname><given-names>AD</given-names></name><name><surname>Michaud</surname><given-names>C</given-names></name><etal/></person-group><article-title>Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010</article-title><source>Lancet Elsevier</source><year>2012</year><volume>380</volume><fpage>2197</fpage><lpage>2223</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)61689-4</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">WHO. Global tuberculosis report 2013. Geneva: World Health Organization; 2013.</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ralph</surname><given-names>AP</given-names></name><name><surname>Kenangalem</surname><given-names>E</given-names></name><name><surname>Waramori</surname><given-names>G</given-names></name><name><surname>Pontororing</surname><given-names>GJ</given-names></name><name><surname>Sandjaja</surname><given-names>TE</given-names></name><etal/></person-group><article-title>High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena</article-title><source>PLoS One. Public Libr Sci</source><year>2013</year><volume>8</volume><fpage>e80302</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0080302</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akkara</surname><given-names>SA</given-names></name><name><surname>Shah</surname><given-names>AD</given-names></name><name><surname>Adalja</surname><given-names>M</given-names></name><name><surname>Akkara</surname><given-names>AG</given-names></name><name><surname>Rathi</surname><given-names>A</given-names></name><name><surname>Shah</surname><given-names>DN</given-names></name></person-group><article-title>Pulmonary tuberculosis: the day after</article-title><source>Int J Tuberc Lung Dis</source><year>2013</year><volume>17</volume><fpage>810</fpage><lpage>813</lpage><pub-id pub-id-type="doi">10.5588/ijtld.12.0317</pub-id><pub-id pub-id-type="pmid">23676167</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlich</surname><given-names>RI</given-names></name><name><surname>Adams</surname><given-names>S</given-names></name><name><surname>Baatjies</surname><given-names>R</given-names></name><name><surname>Jeebhay</surname><given-names>MF</given-names></name></person-group><article-title>Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of south African studies [review article]</article-title><source>Int J Tuberc Lung Dis</source><year>2011</year><volume>15</volume><fpage>886</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.5588/ijtld.10.0526</pub-id><pub-id pub-id-type="pmid">21477424</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">WHO. Global tuberculosis report 2015. Geneva: World Health Organization; 2015.</mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f6;nnroth</surname><given-names>K</given-names></name><name><surname>Roglic</surname><given-names>G</given-names></name><name><surname>Harries</surname><given-names>AD</given-names></name></person-group><article-title>Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. Lancet</article-title><source>Diabetes Endocrinol</source><year>2014</year><volume>2</volume><fpage>730</fpage><lpage>739</lpage></element-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Jeon CY, Murray MB. Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies. Williams B, editor. PLoS Med. Public Libr Sci; 2008;5:e152.</mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, L&#x000f6;nnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Med. BioMed Central Ltd; 2011;9:81.</mixed-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creswell</surname><given-names>J</given-names></name><name><surname>Raviglione</surname><given-names>M</given-names></name><name><surname>Ottmani</surname><given-names>S</given-names></name><name><surname>Migliori</surname><given-names>GB</given-names></name><name><surname>Uplekar</surname><given-names>M</given-names></name><name><surname>Blanc</surname><given-names>L</given-names></name><etal/></person-group><article-title>Tuberculosis and noncommunicable diseases: neglected links and missed opportunities</article-title><source>Eur Respir J</source><year>2011</year><volume>37</volume><fpage>1269</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1183/09031936.00084310</pub-id><pub-id pub-id-type="pmid">20947679</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Rehm J, Samokhvalov A V, Neuman MG, Room R, Parry C, L&#x000f6;nnroth K, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. BioMed Central Ltd; 2009;9:450.</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f6;nnroth</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>BG</given-names></name><name><surname>Cegielski</surname><given-names>P</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name></person-group><article-title>A consistent log-linear relationship between tuberculosis incidence and body mass index</article-title><source>Int J Epidemiol</source><year>2010</year><volume>39</volume><fpage>149</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1093/ije/dyp308</pub-id><pub-id pub-id-type="pmid">19820104</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dallenga</surname><given-names>T</given-names></name><name><surname>Repnik</surname><given-names>U</given-names></name><name><surname>Corleis</surname><given-names>B</given-names></name><name><surname>Eich</surname><given-names>J</given-names></name><name><surname>Reimer</surname><given-names>R</given-names></name><name><surname>Griffiths</surname><given-names>GW</given-names></name><etal/></person-group><article-title>M. tuberculosis -Induced Necrosis of Infected Neutrophils Promotes Bacterial Growth Following Phagocytosis by Macrophages</article-title><source>Cell Host Microbe</source><year>2017</year><volume>22</volume><fpage>519</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2017.09.003</pub-id><pub-id pub-id-type="pmid">29024644</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eum</surname><given-names>SY</given-names></name><name><surname>Kong</surname><given-names>JH</given-names></name><name><surname>Hong</surname><given-names>MS</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Hwang</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB</article-title><source>Chest</source><year>2010</year><volume>137</volume><fpage>122</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1378/chest.09-0903</pub-id><pub-id pub-id-type="pmid">19749004</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MPR</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SAA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1038/nature09247</pub-id><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portevin</surname><given-names>D</given-names></name><name><surname>Moukambi</surname><given-names>F</given-names></name><name><surname>Clowes</surname><given-names>P</given-names></name><name><surname>Bauer</surname><given-names>A</given-names></name><name><surname>Chachage</surname><given-names>M</given-names></name><name><surname>Ntinginya</surname><given-names>NE</given-names></name><etal/></person-group><article-title>Articles assessment of the novel T-cell activation marker &#x02013; tuberculosis assay for diagnosis of active tuberculosis in children&#x000a0;: a prospective proof-of-concept study</article-title><source>Lancet</source><year>2014</year><volume>3099</volume><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>MOC</given-names></name><name><surname>Mendy</surname><given-names>JF</given-names></name><name><surname>Donkor</surname><given-names>S</given-names></name><name><surname>Togun</surname><given-names>T</given-names></name><name><surname>Daramy</surname><given-names>M</given-names></name><name><surname>Gomez</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum</article-title><source>Eur Respir J</source><year>2014</year><volume>44</volume><fpage>254</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1183/09031936.00209913</pub-id><pub-id pub-id-type="pmid">24627540</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comas</surname><given-names>I</given-names></name><name><surname>Gagneux</surname><given-names>S</given-names></name></person-group><article-title>A role for systems epidemiology in tuberculosis research</article-title><source>Trends Microbiol</source><year>2011</year><volume>19</volume><fpage>492</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2011.07.002</pub-id><pub-id pub-id-type="pmid">21831640</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yew</surname><given-names>WW</given-names></name><name><surname>Barer</surname><given-names>MR</given-names></name></person-group><article-title>Targeting persisters for tuberculosis control</article-title><source>Antimicrob Agents Chemother</source><year>2012</year><volume>56</volume><fpage>2223</fpage><lpage>2230</lpage><pub-id pub-id-type="doi">10.1128/AAC.06288-11</pub-id><pub-id pub-id-type="pmid">22391538</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchison</surname><given-names>DA</given-names></name><name><surname>Nunn</surname><given-names>AJ</given-names></name></person-group><article-title>Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis</article-title><source>Am Rev Respir Dis</source><year>1986</year><volume>133</volume><fpage>423</fpage><lpage>430</lpage><?supplied-pmid 2420242?><pub-id pub-id-type="pmid">2420242</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Wallis RS, Wang C, Meyer D, Thomas N. Month 2 Culture Status and Treatment Duration as Predictors of Tuberculosis Relapse Risk in a Meta-Regression Model. Via LE, editor. PLoS One. Public Libr Sci; 2013;8:e71116.</mixed-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barter</surname><given-names>DM</given-names></name><name><surname>Agboola</surname><given-names>SO</given-names></name><name><surname>Murray</surname><given-names>MB</given-names></name><name><surname>B&#x000e4;rnighausen</surname><given-names>T</given-names></name></person-group><article-title>Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa &#x02013; a systematic review</article-title><source>BMC Public Health</source><year>2012</year><volume>12</volume><fpage>980</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-12-980</pub-id><pub-id pub-id-type="pmid">23150901</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanimura</surname><given-names>T</given-names></name><name><surname>Jaramillo</surname><given-names>E</given-names></name><name><surname>Weil</surname><given-names>D</given-names></name><name><surname>Raviglione</surname><given-names>M</given-names></name><name><surname>L&#x000f6;nnroth</surname><given-names>K</given-names></name></person-group><article-title>Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review</article-title><source>Eur Respir J</source><year>2014</year><volume>43</volume><fpage>1763</fpage><lpage>1775</lpage><pub-id pub-id-type="doi">10.1183/09031936.00193413</pub-id><pub-id pub-id-type="pmid">24525439</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f6;nnroth</surname><given-names>K</given-names></name><name><surname>Glaziou</surname><given-names>P</given-names></name><name><surname>Weil</surname><given-names>D</given-names></name><name><surname>Floyd</surname><given-names>K</given-names></name><name><surname>Uplekar</surname><given-names>M</given-names></name><name><surname>Raviglione</surname><given-names>M</given-names></name></person-group><article-title>Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention</article-title><source>PLoS Med. Public Libr Sci</source><year>2014</year><volume>11</volume><fpage>e1001693</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1001693</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Tuberculosis patient cost surveys: a hand book. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hnizdo</surname><given-names>E</given-names></name><name><surname>Singh</surname><given-names>T</given-names></name><name><surname>Churchyard</surname><given-names>G</given-names></name></person-group><article-title>Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment</article-title><source>Thorax</source><year>2000</year><volume>55</volume><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1136/thorax.55.1.32</pub-id><pub-id pub-id-type="pmid">10607799</pub-id></element-citation></ref></